Nicotinamide N‐methyltransferase inhibition mitigates obesity‐related metabolic dysfunction
This work validates NNMT inhibition as a viable pharmacological approach to ameliorate metabolic imbalances and improve liver pathologies that develop with obesity.
Authors
- Stanley J. Watowich (ORCID: https://orcid.org/0000-0002-1660-1818)
- Harshini Neelakantan (ORCID: https://orcid.org/0000-0003-2913-1824)
- JoAnne J. Babula
- Dinh Bui (ORCID: https://orcid.org/0000-0003-2161-5664)
- Heather L. Stevenson (ORCID: https://orcid.org/0000-0002-0645-7621)
Institutions
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-08-19
- DOI
- https://doi.org/10.1111/dom.15879
- Citations
- 6
- Primary Topic
- Sirtuins and Resveratrol in Medicine
- Type
- article
- Field-Weighted Citation Impact
- 2.07
Funders
- Georgia Clinical and Translational Science Alliance
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
- Congressionally Directed Medical Research Programs
- Division of Diabetes, Endocrinology, and Metabolic Diseases